Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
9.25
-1.31 (-12.41%)
Dec 5, 2025, 2:11 PM EST - Market open

Sensei Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
12121746177-
Upgrade
Market Cap Growth
0.38%-28.74%-62.21%-74.21%--
Upgrade
Enterprise Value
-10-30-48-6222-
Upgrade
Last Close Price
10.569.8013.8429.80116.00-
Upgrade
PB Ratio
0.580.320.270.441.21-
Upgrade
P/TBV Ratio
0.580.320.270.441.21-
Upgrade
Debt / Equity Ratio
0.090.100.100.080.020.04
Upgrade
Quick Ratio
5.657.5911.6511.8230.203.44
Upgrade
Current Ratio
5.817.7011.9211.9830.384.16
Upgrade
Return on Equity (ROE)
-70.18%-58.40%-40.52%-38.88%-45.31%-
Upgrade
Return on Assets (ROA)
-37.04%-32.32%-24.04%-23.10%-26.83%-103.30%
Upgrade
Return on Capital (ROIC)
-39.78%-34.15%-25.38%-24.10%-28.32%-203.12%
Upgrade
Return on Capital Employed (ROCE)
-103.50%-77.60%-53.90%-45.90%-25.30%-112.70%
Upgrade
Earnings Yield
-181.23%-244.65%-197.14%-106.15%-20.73%-
Upgrade
FCF Yield
-168.16%-201.32%-186.17%-85.96%-18.19%-
Upgrade
Buyback Yield / Dilution
-0.52%10.14%8.96%-10.80%-1618.88%-338.85%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q